Video: Logistics Leaders - How the biopharma industry impacts materials stored in depots
Paula Pulsoni, Director, Global Operations - CSS discusses the benefits of our storage facilities
At the beginning our facilities were clearly designed to store IMP. The strict control to temperature and the complexity to manage serialised product was the key factor but today we store much more than that. We store medical devices, clinical trial-related materials, and even documentation connected with the trial. In some locations we store APIs and also commercial medication which can be related to a trial or can be purely commercial activity like the 3PL warehouse we have in Australia. The benefit for the client is that they get to work with a single provider at all stages. We want to be there at inception and work all the way through until the commercialization of the drug.
Article: Untapped Opportunities in Southeast Asia
Southeast Asia is a growing pharmaceutical market with an increase in clinical trials in recent years. But what opportunities are there for multinational companies to embark on activity outside of the already well recognized study destinations?